Guest Commentary in Drug Discovery News (DDN) by Andreas Persidis September 2011 After many years of talking about it, the patent cliff is finally with us in a big way. Starting with Pfizer’s Lipitor this coming November, Big Pharma is projected to lose more than $60 billion in the next five to six years from … Read More
Author: Christos Andronis
Undercover COSS
Biovista’s drug safety search aids clinical outcomes. Interview to Bio-IT World By Kevin Davies June 8, 2011 | Biovista began as a hobby,” admits the company’s eloquent president, Aris Persidis. But after “dabbling” with the firm for a few years, Persidis incorporated the company in the United States in 2005. Headquartered in Charlottesville, Virginia, Biovista … Read More
The benefits of drug repositioning
Guest Commentary in Drug Discovery World (DDW) by Aris Persidis, Biovista’s President Spring 2011 Drugs in development, on the market, or those that are shelved because of lack of efficacy, are excellent starting points for further development. Finding new indications for such drugs will benefit patients who will see a potential new therapy sooner, will … Read More
FirstWord: Drug Combinations: New Rules, New Opportunities
Biovista featured in FirstWorld’s latest report, “Drug Combinations: New Rules, New Opportunities” For years, drug therapy has been built on that basic equation. Yet as genomic biology sheds light on the astonishing intricacy of disease pathology, it is clear that drugs that combine several compounds must be developed in response. According to Biovista president … Read More
Biovista Awarded $0.5M to Participate in EC’s Personalized Medicine Initiative
Article in GEN on Biovista’s participation in the Eurpean “p-medicine” project. Drug repositioning specialist Biovista’s European affiliate has been awarded a $0.5 million grant to fund its participation in the European Commission’s €13.3 million (roughly $19.7 million), four-year p-medicine project focused on developing new tools and virtual physiological human (VPH) models to speed the development … Read More